Remove 2017 Remove Compounding Remove FDA
article thumbnail

Gaps Remain in MOUD Access Across Opioid Treatment Programs

Drug Topics

From 2017 to 2023, the percentage of all opioid treatment programs offering 3 forms of medication for opioid use disorder (OUD) increased from 33% to 45%, but there is still a need to expand the offerings of OUD therapy across treatment programs. 1 Data from 10,289 facility-year observations were used, with 1211 in 2017 and 1421 in 2023.

article thumbnail

Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable

Drug Topics

Approximately 31% of people in the United States were overweight and 42% were obese in 2017 to 2018, compared with 34% and 30.5% " Obesity has risen considerably over the past 3 years, according to data from the Pew Research Center. in 1999 to 2000, respectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy

Drug Topics

2017 Oct 10;17(1):230. National Institute on Aging. August 24, 2021. Accessed July 18, 2025. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? a systematic review of definitions. BMC Geriatr. doi: 10.1186/s12877-017-0621-2. Newsletter Pharmacy practice is always changing.

article thumbnail

7 health benefits of raspberry leaf tea

The Checkup by Singlecare

Red raspberry leaves are rich in tannins (a chemical compound) and flavonoids (a plant pigment), which both have antioxidant properties, according to research in Antioxidants journal. A 2017 study demonstrated that ellagic acid can inhibit pancreatic cancer growth. But what about the leaves?

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Drug Topics

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release.

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. The phase 3 ECHO trial showed significant progression-free survival improvement with acalabrutinib, supporting its approval as a new standard of care for untreated MCL.

FDA